A Form 144 notice of proposed sale was filed on November 4, 2026, on behalf of the David & Laura Francis Joint Revocable Trust, disclosing plans to sell 75,000 shares of SI-BONE, Inc. common stock on NASDAQ.
Key Highlights
- Seller: DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, with Laura Francis identified as a Director and Officer of SI-BONE, Inc.
- Shares proposed for sale: 75,000 shares of common stock, with an aggregate market value of $1,782,750.00.
- Shares outstanding: 45,113,087 shares of SI-BONE common stock outstanding as reported in the filing.
- Acquisition: Securities were acquired as Restricted Stock Units from the issuer, with 75,000 units recorded as acquired on May 15, 2021.
- Approximate date of sale: November 4, 2026, through broker Morgan Stanley Smith Barney LLC Executive Financial Services.
- 10b5-1 plan: The filing indicates reliance on a Rule 10b5-1 plan adopted on May 21, 2026.
- Prior three-month sales: Combined prior sales by the trust and Laura Francis totaled 134,741 shares across four 10b5-1 transactions and one additional sale between August 17, 2026, and October 12, 2026.
SI-BONE Director and Officer Trust Proposes 75,000-Share Sale Under Rule 144
According to the filing, the DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, in which Laura Francis holds relationships listed as both Director and Officer of SI-BONE, Inc. (NASDAQ:SIBN), filed a Form 144 notice on November 4, 2026. The notice covers a proposed sale of 75,000 shares of SI-BONE common stock at an aggregate market value of $1,782,750.00, with Morgan Stanley Smith Barney LLC Executive Financial Services named as the executing broker. The company's address is listed as 88 West Plumeria Drive, San Jose, California 95134.
The filing states that the securities to be sold "were acquired upon the vesting of restricted stock units during the period of 5/15/2021 through 11/15/2025," with the acquisition transaction recorded as 75,000 Restricted Stock Units received from the issuer, dated May 15, 2021. Payment is listed as N/A. The proposed sale is described as occurring under a Rule 10b5-1 trading plan adopted on May 21, 2026.
The filing also discloses sales by the trust and by Laura Francis over the prior three months. These include four 10b5-1 transactions by the trust: 38,006 shares sold on October 12, 2026 (gross proceeds $762,012.70); 25,972 shares on August 24, 2026 ($522,595.60); 3,923 shares on August 21, 2026 ($78,556.90); and 51,884 shares on August 20, 2026 ($1,009,558.87). Additionally, 14,956 shares were sold by Laura Francis on August 17, 2026, with gross proceeds of $279,064.67. The filing was signed by Laura Francis.
What Was Disclosed
A Form 144 was filed for the David & Laura Francis Joint Revocable Trust, disclosing a proposed sale of 75,000 SI-BONE common shares valued at $1,782,750.00, acquired as RSUs, under a 10b5-1 plan adopted May 21, 2026, with an approximate sale date of November 4, 2026.




Please wait processing your request...